RITUXIMAB THERAPY IN A PATIENT WITH LOW GRADE B-CELL LYMPHOPROLIFERATIVE DISEASE AND CONCOMITANT ACQUIRED ANGIOEDEMA

Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema

Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema

Blog Article

Ravdeep Kaur, Aerik Anthony Williams, Catherine Baker Swift, Jason W Caldwell Wake Forest University School of Medicine, Wake Forest University, Disposable Masks Winston-Salem, NC, USA Abstract: Acquired angioedema is often associated with significant morbidity.An underlying lymphatic malignancy, autoimmune disorder, adenocarcinoma, or other malignancy may be present.Screening for these disorders Pre-Rolls should occur in all patients with acquired angioedema as treatment may result in resolution of angioedema.Keywords: complement, C1-INH deficiency, ecallantide, hemopathy.

Report this page